![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
Target Class: Oxidoreductases Disease Areas: Site: Oxford Status: Pending-Official Structure |
||
Target Class: Bromodomain Disease Areas: Cancer, Chromatin and epigenetics, Signalling Site: Oxford Status: Follow-up not counted |
||
Target Class: Bromodomain Disease Areas: Cancer, Chromatin and epigenetics, Signalling Site: Oxford Status: Follow-up not counted |
||
Target Class: Bromodomain Disease Areas: Cancer, Chromatin and epigenetics, Signalling Site: Oxford Status: Follow-up not counted |
||
Target Class: Bromodomain Disease Areas: Cancer, Chromatin and epigenetics, Signalling Site: Oxford Status: Follow-up not counted |
||
Target Class: Bromodomain Disease Areas: Cancer, Chromatin and epigenetics, Signalling Site: Oxford Status: Follow-up not counted |
||
Target Class: Bromodomain Disease Areas: Cancer, Chromatin and epigenetics, Signalling Site: Oxford Status: Follow-up not counted |
||
Target Class: Miscellaneous Disease Areas: Site: Oxford Status: Pending-Official Structure |
||
Target Class: Transferases Disease Areas: Cancer, Chromatin and epigenetics Site: Toronto Status: Follow-up official |
||
Target Class: Miscellaneous Disease Areas: Site: Oxford Status: Pending-Official Structure |
||
Target Class: Transferases Disease Areas: Cancer, Chromatin and epigenetics Site: Toronto Status: Follow-up official |
||
Target Class: Transferases Disease Areas: Chromatin and epigenetics Site: Toronto Status: Pending-Official Structure |
||
Target Class: Miscellaneous Disease Areas: Cancer Site: Toronto Status: Pending-Official Structure |
||
Target Class: Miscellaneous Disease Areas: Neurobiology Site: Toronto Status: Pending-Official Structure |
||
Target Class: Protein Kinase Disease Areas: Parasitic disease Site: Toronto Status: Follow-up official |
||
Target Class: Miscellaneous Disease Areas: Cancer Site: Toronto Status: Pending-Official Structure |
||
Target Class: Protein Kinase Disease Areas: Parasitic disease Site: Toronto Status: Follow-up official |
||
Target Class: Protein Kinase Disease Areas: Parasitic disease Site: Toronto Status: Follow-up not counted |
||
Target Class: Methyl-lysine readers Disease Areas: Chromatin and epigenetics Site: Toronto Status: Pending-Official Structure |
||
Target Class: Miscellaneous Disease Areas: Cancer Site: Toronto Status: Pending-Official Structure |
||
Target Class: Protein Kinase Disease Areas: Parasitic disease Site: Toronto Status: Follow-up not counted |
||
Target Class: Miscellaneous Disease Areas: Parasitic disease Site: Toronto Status: Pending-Official Structure |
||
Target Class: Miscellaneous Disease Areas: Cancer, Chromatin and epigenetics Site: Toronto Status: Follow-up not counted |
||
Target Class: Membrane proteins Disease Areas: Site: Oxford Status: Follow-up not counted |
||
Target Class: Protein Kinase Disease Areas: Cancer Site: Oxford Status: Pending - Official structure |
||
Target Class: Miscellaneous Disease Areas: Signalling Site: Toronto Status: Official |
||
Target Class: Nuclear Receptors Disease Areas: Site: Oxford Status: Pending-Official Structure |
||
Target Class: Miscellaneous Disease Areas: Site: Oxford Status: Pending-Official Structure |
||
Target Class: Miscellaneous Disease Areas: Site: Oxford Status: Pending-Official Structure |
||
Target Class: Membrane proteins Disease Areas: Site: Oxford Status: Follow-up official |
||
Target Class: Oxidoreductases Disease Areas: Site: Oxford Status: Pending-Official Structure |
||
Target Class: Transferases Disease Areas: Chromatin and epigenetics Site: Toronto Status: Follow-up not counted |
||
Target Class: Proteases Disease Areas: Parasitic disease Site: Toronto Status: Follow-up not counted |
||
Target Class: Bromodomain Disease Areas: Cancer, Chromatin and epigenetics, Signalling Site: Oxford Status: Follow-up not counted |
||
Target Class: Bromodomain Disease Areas: Cancer, Chromatin and epigenetics, Signalling Site: Oxford Status: Follow-up not counted |
||
Target Class: Bromodomain Disease Areas: Cancer, Chromatin and epigenetics, Signalling Site: Oxford Status: Follow-up not counted |
||
Target Class: Methyltransferases Disease Areas: Cancer, Chromatin and epigenetics Site: Toronto Status: Pending-Official Structure |
||
Target Class: Bromodomain Disease Areas: Cancer, Chromatin and epigenetics, Signalling Site: Oxford Status: Follow-up not counted |
||
Target Class: Oxidoreductases Disease Areas: Site: Oxford Status: Pending-Official Structure |
||
Target Class: PDZ linkers Disease Areas: Site: Oxford Status: Pending-Official Structure |
||
Target Class: Miscellaneous Disease Areas: Signalling Site: Toronto Status: Pending-Official Structure |
||
Target Class: Protein Kinase Disease Areas: Site: Oxford Status: Follow-up not counted |
||
Target Class: Methyl-lysine readers Disease Areas: Chromatin and epigenetics Site: Toronto Status: Pending-Official Structure |
||
Target Class: Methyltransferases Disease Areas: Chromatin and epigenetics Site: Toronto Status: Follow-up official |
||
Target Class: Protein Kinase Disease Areas: Cancer Site: Oxford Status: Follow-up not counted |
||
Target Class: Protein Kinase Disease Areas: Cancer Site: Oxford Status: Pending-Official Structure |
||
Target Class: Protein Kinase Disease Areas: Cancer, Chromatin and epigenetics, Signalling Site: Oxford Status: Follow-up not counted |
||
Target Class: Oxidoreductases Disease Areas: Cancer, Metabolism, Signalling Site: Oxford Status: Pending Not counted |
||
Target Class: Oxidoreductases Disease Areas: Metabolism, Cancer, Signalling Site: Oxford Status: Pending - Official structure |
||
Target Class: Miscellaneous Disease Areas: Site: Oxford Status: Pending - Official structure |
||
Target Class: Bromodomain Disease Areas: Cancer, Chromatin and epigenetics, Signalling Site: Oxford Status: Follow-up not counted |
||
Target Class: Proteases Disease Areas: Parasitic disease Site: Toronto Status: Follow-up not counted |
||
Target Class: G-Protein Regulators Disease Areas: Neurobiology Site: Toronto Status: Pending-Official Structure |
||
Target Class: Oxidoreductases Disease Areas: Site: Oxford Status: Pending-Official Structure |
||
Target Class: Oxidoreductases Disease Areas: Cancer, Chromatin and epigenetics Site: Oxford Status: Follow-up not counted |
||
Target Class: DExD-DExH RNA helicases Disease Areas: Site: Oxford Status: Pending-Official Structure |
||
Target Class: Methyl-lysine readers Disease Areas: Cancer, Chromatin and epigenetics Site: Toronto Status: Pending-Official Structure |
||
Target Class: Deubiquitinating Enzymes - USP, Ubiquitin Related Biology Disease Areas: Cancer Site: Toronto Status: Official |
||
Target Class: Proteases Disease Areas: Parasitic disease Site: Toronto Status: Pending-Official Structure |
||
Target Class: Miscellaneous Disease Areas: Site: Oxford Status: Follow-up official |
||
Target Class: Miscellaneous Disease Areas: Signalling Site: Toronto Status: Pending - Official structure |
||
Target Class: Methyl-lysine readers Disease Areas: Chromatin and epigenetics Site: Toronto Status: Pending - Official structure |
||
Target Class: Protein Kinase Disease Areas: Site: Oxford Status: Pending-Official Structure |
||
Target Class: Protein Kinase Disease Areas: Cancer, Signalling, Neurobiology Site: Oxford Status: Follow-up not counted |
||
Target Class: Protein Kinase Disease Areas: Cancer, Metabolism, Signalling, Neurobiology Site: Oxford Status: Follow-up not counted |
||
Target Class: Miscellaneous Disease Areas: Site: Oxford Status: Pending-Official Structure |
||
Target Class: Membrane proteins Disease Areas: Site: Oxford Status: Follow-up not counted |
||
Target Class: Ubiquitin Related Biology, Ubiquitylation - E3 Ligases Disease Areas: Signalling Site: Toronto Status: Pending-Official Structure |
||
Target Class: Transferases Disease Areas: Signalling Site: Toronto Status: Pending-Official Structure |
||
Target Class: Transferases Disease Areas: Chromatin and epigenetics Site: Toronto Status: Pending-Official Structure |
||
Target Class: Bromodomain Disease Areas: Cancer, Chromatin and epigenetics, Signalling Site: Oxford Status: Follow-up official |
||
Target Class: Miscellaneous Disease Areas: Signalling Site: Toronto Status: Pending - Official structure |
||
Target Class: Miscellaneous Disease Areas: Signalling Site: Toronto Status: Pending - Official structure |
||
Target Class: Miscellaneous Disease Areas: Signalling Site: Toronto Status: Pending - Official structure |
||
Target Class: Methyl-lysine readers Disease Areas: Chromatin and epigenetics Site: Toronto Status: Pending-Official Structure |
||
Target Class: Membrane proteins Disease Areas: Site: Oxford Status: Pending-Official Structure |
||
Target Class: Miscellaneous Disease Areas: Cancer, Chromatin and epigenetics Site: Toronto Status: Pending-Official Structure |
||
Target Class: Miscellaneous Disease Areas: Site: Oxford Status: Follow-up official |
||
Target Class: Protein Kinase Disease Areas: Site: Oxford Status: Pending-Official Structure |
||
Target Class: Miscellaneous Disease Areas: Site: Oxford Status: Pending-Official Structure |
||
Target Class: Miscellaneous Disease Areas: Site: Oxford Status: Pending-Official Structure |
||
Target Class: Miscellaneous Disease Areas: Metabolism Site: Toronto Status: Pending-Official Structure |
||
Target Class: Protein Kinase Disease Areas: Cancer Site: Oxford Status: Follow-up not counted |
||
Target Class: Miscellaneous Disease Areas: Cancer Site: Oxford Status: Pending-Official Structure |
||
Target Class: Miscellaneous Disease Areas: Site: Oxford Status: Pending-Official Structure |
||
Target Class: Transferases Disease Areas: Cancer, Chromatin and epigenetics Site: Toronto Status: Follow-up not counted |
||
Target Class: Transferases Disease Areas: Cancer, Chromatin and epigenetics Site: Toronto Status: Follow-up not counted |
||
Target Class: Transferases Disease Areas: Cancer, Chromatin and epigenetics Site: Toronto Status: Follow-up official |
||
Target Class: Transferases Disease Areas: Cancer, Chromatin and epigenetics Site: Toronto Status: Follow-up not counted |
||
Target Class: Transferases Disease Areas: Cancer, Chromatin and epigenetics Site: Toronto Status: Follow-up not counted |
||
Target Class: Transferases Disease Areas: Cancer, Chromatin and epigenetics Site: Toronto Status: Follow-up not counted |
||
Target Class: Non-protein Kinase Disease Areas: Cancer Site: Oxford Status: Follow-up not counted |
||
Target Class: Miscellaneous Disease Areas: Site: Oxford Status: Pending-Official Structure |
||
Target Class: Miscellaneous Disease Areas: Site: Oxford Status: Pending-Official Structure |
||
Target Class: Miscellaneous Disease Areas: Site: Oxford Status: Follow-up not counted |
||
Target Class: Protein Kinase Disease Areas: Cancer, Signalling Site: Oxford Status: Follow-up official |
||
Target Class: Transferases Disease Areas: Parasitic disease Site: Toronto Status: Pending-Official Structure |
||
Target Class: Proteases Disease Areas: Parasitic disease Site: Toronto Status: Pending-Official Structure |
||